Red Mountain Compounding Recalls S-HCG 3000 U/ML Due to Sterility Concerns
Red Mountain Compounding Pharmacy is recalling S-HCG 3000 U/ML vials because the FDA determined there is a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the hazard involves a lack of assurance of sterility in a medical product, which aligns with the rubric criteria for Severe severity involving significant injury risks or Class II classifications with potential for serious harm.
Plain-English summary
First Royal Care Co. LLC, doing business as Red Mountain Compounding Pharmacy, is recalling S-HCG 3000 U/ML MDV SOLN, 10 ML glass vials. The recall was initiated due to a lack of assurance of sterility in the product.
The affected product is prescription-only and was distributed nationwide in the USA. The recall covers 8x10 ML vials from specific lots: S06272019DT@07 (Exp 8/27/19), S07262019DH@04 (Exp 9/26/19), and S07302019DH@04 (Exp 9/30/19).
Consumers should check their medication for these specific lot numbers and expiration dates. If the product matches the recalled description, they should stop using it and contact their healthcare provider or the recalling firm for instructions on disposal or replacement.
The recalled product
- Product
- S-HCG 3000 U/ML MDV SOLN, 10 ML glass vials, Rx Only, Red Mountain Compounding Rx.
- Category
- Drug — Compounded Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: S06272019DT@07
- Exp 8/27/19
- S07262019DH@04
- Exp 9/26/19
- S07302019DH@04
- Exp 9/30/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 100 recalled by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 100 products in this recall →Related recalls
Same manufacturer · First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
See all →- SevereMIT/B12 Compounded Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- HighTestosterone Ultra 250MG/ML Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- SevereRed Mountain Compounding Test Cypionate Sterility Assurance Recall
FDA (Drugs) · 2021-11-03
- SevereTEST CYP/PROP Compounded Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- HighTEST CYP 25MG/ML Injectable Lacks Assurance of Sterility
FDA (Drugs) · 2021-11-03
Same hazard · sterility
See all →- SevereFDA Recalls Testosterone Cypionate Vials Due to Sterility Concerns
FDA (Drugs) · 2026-10-28
- SevereHeparin Sodium Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-10-28
- SevereHouston Rx LLC Recalls Tirzepatide/Niacinamide Vials Due to Sterility Concerns
FDA (Drugs) · 2026-10-21
- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereMethylcobalamin Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- ModerateMethylcobalamin injection recalled due to sterility assurance concerns
FDA (Drugs) · 2021-11-03
- HighPyridoxine HCL Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-03
- SevereMIT/B12 Compounded Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- SevereMethylcobalamin Injectable: Sterility Assurance Deficiency
FDA (Drugs) · 2021-11-03
- SevereFolic Acid 10mg/mL Injectable Recalled Due to Sterility Concerns
FDA (Drugs) · 2021-11-03